(Q35826324)

10 August 2017

1 reference

title

What is the best size descriptor to use for pharmacokinetic studies in the obese? (English)

1 reference

10 August 2017

0 references

1 reference

Stephen B Duffull

2

0 references

author name string

Bruce Green

series ordinal

1

1 reference

PMC publication ID

1884581

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

58

1 reference

10 August 2017

2

1 reference

10 August 2017

119-133

1 reference

Development of a dosing strategy for enoxaparin in obese patients

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Effects of obesity on pharmacokinetics implications for drug therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Obesity as a medical problem

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Clinical pharmacokinetics of drugs in obesity. An update

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Lean body mass as a predictor of drug dosage. Implications for drug therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

The pharmacokinetics of dexfenfluramine in obese and non-obese subjects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Vancomycin pharmacokinetics in normal and morbidly obese subjects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Relationship between total body water and surface area in normal and obese subjects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Body composition in obesity.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Estimation of the fat-free mass of twenty subjects from measurements of total body potassium, body density, skinfold thickness, and height and weight

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Indices of relative weight and obesity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

The relation of total body potassium to height, weight, and age in normal adults

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

A comparison of the pharmacokinetics of propranolol in obese and normal volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Validation of tetrapolar bioelectrical impedance method to assess human body composition

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Simplified calculation of body-surface area.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Effect of obesity on bioelectrical impedance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

A formula to estimate the approximate surface area if height and weight be known. 1916.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Renal hemodynamics in recent-onset type II diabetes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Prediction of creatinine clearance from serum creatinine

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Nutritional and metabolic assessment of the hospitalized patient

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

A standard weight descriptor for dose adjustment in the obese patient

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Performance of target-controlled sufentanil infusion in obese patients

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Caution when lean body weight is used as a size descriptor for obese subjects

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Obesity, body fat distribution, and ambulatory blood pressure in children and adolescents

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Obesity and disease management: effects of weight loss on comorbid conditions

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Assessment of actual significance levels for covariate effects in NONMEM.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

The effect of body weight on dalteparin pharmacokinetics. A preliminary study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

The influence of renal function on the pharmacokinetics and pharmacodynamics and simulated time course of doxacurium

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Remifentanil pharmacokinetics in obese versus lean patients.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Population pharmacokinetics of total and unbound etoposide.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

How to predict carboplatin clearance from standard morphological and biological characteristics in obese patients.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Carbamazepine pharmacokinetics in obese and lean subjects.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Bayesian estimation of p-aminohippurate clearance by a limited sampling strategy.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

Prolongation of drug half-life due to obesity: studies of desmethyldiazepam (clorazepate).

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884581

24 September 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02157.X

Caffeine pharmacokinetics in obesity and following significant weight reduction

21 January 2018

1 reference

12 December 2020

Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution

1 reference

12 December 2020

Glomerular filtration rate in severely overweight normotensive humans

1 reference

12 December 2020

The assessment of the amount of fat in the human body from measurements of skinfold thickness

1 reference

12 December 2020

Vancomycin dosing in morbidly obese patients

1 reference

12 December 2020

Pharmacokinetic considerations in obesity

1 reference

12 December 2020

The impact of obesity and disease on busulfan oral clearance in adults

1 reference

12 December 2020

A Comparison of the Fat-Free Mass of Young Adults Estimated by Anthropometry, Body Density and Total Body Potassium Content

1 reference

12 December 2020

Erroneous nomograms for body-surface area

1 reference

12 December 2020

Tobramycin pharmacokinetics in morbidly obese patients

1 reference

12 December 2020

Amikacin pharmacokinetics in morbidly obese patients

1 reference

12 December 2020

Procainamide Disposition in Obesity

1 reference

12 December 2020

The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and Triazolam

1 reference

12 December 2020

Phenytoin disposition in obesity. Determination of loading dose

1 reference

12 December 2020

Doxorubicin clearance in the obese

1 reference

12 December 2020

Pharmacokinetics of ranitidine in morbidly obese women

1 reference

12 December 2020

Population pharmacokinetics of lithium

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics

1 reference

12 December 2020

Lithium pharmacokinetics in the obese

1 reference

12 December 2020

Effect of body weight on the volume of distribution of theophylline

1 reference

12 December 2020

10.1111/J.1365-2125.2004.02157.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

PMC publication ID

1884581

10 August 2017

PubMed publication ID

15255794

1 reference

PMC publication ID

1884581